From: The expression of HSP27 is associated with poor clinical outcome in intrahepatic cholangiocarcinoma
Variable | Hazard Ratio | 95%CI | P-Value |
---|---|---|---|
Age | 1.03 | 0.97 – 1.1 | 0.33 |
Gender | 0.68 | 0.21 – 2.22 | 0.52 |
Tumor Border Growth(1) | 3 | 0.85 – 10.6 | 0.088 |
Multiple nodules | 0.923 | 0.31 – 2.75 | 0.89 |
Vascular Inv. | 3.18 | 1.08 – 9.33 | 0.036 |
Capsular Inv. | 3.95 | 1.20 – 12.9 | 0.024 |
Resected margins invasion | 1.79 | 0.55 – 5.82 | 0.33 |
Tumor mass(2) | 1.30 | 0.95 – 1.79 | 0.100 |
Number of resected segments | 0.914 | 0.68 – 1.23 | 0.55 |
HSP27 | 18.5 | 3.83 – 89.6 | 0.0003 |
HSP72 | 1.99 | 0.66 – 5.94 | 0.22 |
Stage (3) | 7.315 | 1.46 – 122.6 | 0.032 |